Searched for
FAVIPIRAVIR 200 MG
MSN Labs launches black fungus drug Posaconazole in IndiaMSN Labs had earlier launched a Covid treatment portfolio of Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg, Oselow (Osel...- MSN Labs ties up with Eli Lilly for baricitinib in IndiaAs part of the COVID treatment range, MSN has already launched Favilow (Favipiravir) in the strengths of 200mg, 400mg and 800mg and Oselow ...
- Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in IndiaFavipiravir is one of the leading oral anti-viral treatment approved in various countries for the potential treatment of patients with mild...
- Gujarat: Demand for Remdesivir, oxygen falls as new cases decline"Cases of coronavirus in the state are declining and the demand and consumption of medical oxygen, Remdesivir injections and Favipiravir ta...
- After tablets, Hetero working on antiviral medicine Favipiravir injectionsIf successful, Hetero will become the first Indian drug maker to introduce favipiravir in injection form which is hitherto available only i...
- Hetero launches pack of generic COVID-19 drug favipiravir at Rs 2,640"The launch of 'Favivir 800/200' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are re...
- BDR Pharma to launch 400mg Favipiravir tablets for treating coronavirus patients in IndiaThe company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild ...
- Dr Reddy's launches antiviral drug Avigan in India, to launch remdesivir in SeptemberIndian generic drug maker Dr Reddy's Laboratories on Wednesday announced the launch of antiviral drug Avigan (favipiravir) tablets, current...
- Glenmark to launch higher strength of FabiFlu for mild and moderate symptoms of Covid-19The higher strength will improve compliance for patients by effectively reducing the number of tablets required per day, Glenmark said in a...
- BDR Pharmaceuticals launches Favipiravir under brand name 'BDFAVI' at Rs 63 per tablet in IndiaBDR pharma has received an approval from the DCGI to manufacture Favipiravir to treat mild to moderate patients with COVID-19 symptoms. The...
- Lupin launches coronavirus drug Favipiravir in India at Rs 49 per tabletFavipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use, Lupin said in a regulatory filin...
- Sun Pharma latest to sell COVID-19 drug favipiravir in India, to cost Rs 35 per tabletFavipiravir, along with another antiviral, remdesivir, has emerged as one of the most sought-after drugs at hospitals fighting COVID-19 in ...
- Indian drug companies start off a price war on experimental Covid-19 drugOver the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...
- Favirpiravir yet to find favour with ICMRHowever, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET ...
- Glenmark launches COVID-19 drug after DCGI nod; MRP at Rs 103 per tabletThe company hopes that the availability of an effective treatment such as FabiFlu will considerably help assuage this pressure, and offer p...
- Favipiravir and Remdesivir get approval for treatment“Under an accelerated approval process at the Central Drugs Standard Control Organisation (CDSCO), the Subject Expert Committee (SEC) has r...
- Glenmark launches Favipiravir: Medics say 'no magic bullet' for COVID but will help amid rising cases"This drug was already being used in Japan for influenza. They have been using it in COVID-19 patients also. Even China was using it and Ru...
- Glenmark Pharma drops 5% after HSBC Pooled Investment Fund sold stakeAfter rallying 27 per cent in the previous session, the scrip traded 5.24 per cent lower at Rs 492.
- Glenmark Pharma surges 35%, sees biggest intraday rise in history on Covid-19 drug launchThe firm launched antiviral drug Favipiravir for the treatment of Covid-19 patients.
- Strides Pharma develops Favipiravir antiviral tablets; drug shows positive outcome in COVID-19 treatmentStrides Pharma Science Ltd on Wednesday said it has developed and commercialised Favipiravir antiviral tablets and stressed that the drug h...
Load More
